Vitamin D and cardiometabolic health: a review of the evidence
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The cardiometabolic syndrome (MetS) is a clustering of related metabolic abnormalities including abdominal adiposity, insulin resistance, hypertension, dyslipidaemia and increased inflammatory and thrombotic markers, which is linked to increased risk of type 2 diabetes, CVD and overall mortality. Several cross-sectional and prospective studies have shown an association between low vitamin D status, as indicated by concentrations of serum 25-hydroxyvitamin D (s25(OH)D), and increased prevalence of the MetS and individual CVD risk factors. These epidemiological observations are supported by mechanistic studies but experimental data are limited. The available data from intervention studies are largely confounded as most vitamin D supplementation trials were mainly carried out to explore the role of Ca in CVD and include Ca in the treatment arms. Inadequate consideration of seasonal effects on s25(OH)D concentrations is also a common design flaw in most studies. Further complications arise from shared risk factors such as adiposity and ageing, which predispose individuals to exhibit both a more pronounced risk profile and relatively lower s25(OH)D concentrations. In conclusion, while epidemiological associations are promising and a rationale for low vitamin D status as a potentially modifiable risk factor for CVD is supported by mechanistic data, suitable experimental data from appropriately designed trials are just beginning to emerge. As yet, this body of literature is too immature to draw firm conclusions on the role of vitamin D in CVD prevention. Carefully controlled vitamin D trials in well-described population groups using intervention doses that are titrated against target s25(OH)D concentrations could yield potentially valuable outcomes that may have a positive impact on CVD risk modification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Decreased bioavailability of vitamin D in obesity
Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.690 · Cited by 3,204 · cited 1×
“to sequester cholecalciferol and 25(OH)D, making it unavailable to the circulation; thus obese individuals frequently have low s25(OH)D concentrations((104)).”
BackgroundWRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625 · cited 2×
“Experimental studies (either animal or cell) have shown that 1,25(OH)2D regulates MMP expression ((118,207,209)).”
BackgroundGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135
Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099 · cited 2×
“Additionally, if the findings of the recent meta-analysis((32)) with regard to cardiovascular events are correct, giving Ca with vitamin D may occlude the possible beneficial effects of vitamin D.”
BackgroundAmerican College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Research works printed but not linked: 187
- 10.1161/CIRCULATIONAHA.107.706127 · DOI · Paper page
- 10.1017/S0954422409389301 · DOI · Paper page
- 10.1038/nature01323 · DOI · Paper page
- 10.1186/1471-2199-9-65 · DOI
- 10.1161/01.ATV.12.6.671 · DOI · Paper page
- 10.7326/0003-4819-105-5-649 · DOI · Paper page
- Borissova, 2003, The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients, Int J Clin Pract, 57, 258, 10.1111/j.1742-1241.2003.tb10480.x · DOI · Paper page
- 10.1007/s00125-005-0047-9 · DOI
- 10.1016/j.metabol.2008.01.011 · DOI
- 10.1016/j.maturitas.2008.12.020 · DOI
- 10.1016/S1262-3636(07)70200-8 · DOI
- Kelly, 2005, Seasonal variations of selected cardiovascular risk factors, Altern Med Rev, 10, 307
- 10.1016/0960-0760(94)00153-D · doi:10.1016/0960-0760(94)00153-d
- Pfeifer, 2001, Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women, J Clin Endocrinol Metab, 86, 1633
- Kylin, 1923, Studien uber das Hypertonie-Hyperglyka ‘mie-Hyperurika’ Miesyndrom (Studies of the hypertension–hyperglycemia–hyperuricemia syndrome), Zentralbl Inn Med, 44, 105
- 10.1016/j.cardiores.2005.11.003 · DOI · Paper page
- 10.1016/j.jsbmb.2006.12.081 · DOI · Paper page
- 10.1172/JCI117809 · DOI · Paper page
- 10.1161/HYPERTENSIONAHA.107.087288 · DOI · Paper page
- 10.1001/jama.288.14.1723 · DOI · Paper page
- 10.1093/ajcn/80.6.1717S · DOI · Paper page
- 10.1111/j.1365-2796.2009.02181.x · DOI · Paper page
- 10.1080/09513590802302985 · doi:10.1080/09513590802302985
- 10.1001/archinte.168.12.1340 · DOI · Paper page
- 10.1093/ajcn/83.4.754 · DOI · Paper page
- 10.1016/j.nut.2007.11.006 · DOI · Paper page
- 10.1210/jc.2002-020978 · DOI · Paper page
- 10.1001/jama.287.3.356 · DOI · Paper page
- 10.2337/diacare.29.03.06.dc05-2148 · DOI · Paper page
- 10.1056/NEJM200006153422406 · DOI · Paper page
- 10.1016/0168-8227(95)01040-K · DOI · Paper page
- 10.2337/dc07-1829 · DOI · Paper page
- 10.1016/j.jsbmb.2004.03.115 · DOI · Paper page
- 10.1016/0021-9150(77)90139-3 · DOI
- 10.1530/EJE-08-0072 · DOI · Paper page
- 10.1016/S0140-6736(04)17018-9 · DOI · Paper page
- 10.1161/HYPERTENSIONAHA.109.143990 · DOI
- 10.2337/diacare.27.12.2813 · DOI · Paper page
- 10.1111/j.1365-2796.2007.01778.x · DOI · Paper page
- 10.1055/s-2003-44711 · DOI
- 10.3181/00379727-132-34148 · doi:10.3181/00379727-132-34148
- 10.1093/eurheartj/ehi373 · DOI · Paper page
- 10.1530/eje.0.1370495 · DOI · Paper page
- 10.1136/bmj.3.5932.647 · DOI
- Lacour, 1982, Parathyroid function and lipid metabolism in the rat, Miner Electrolyte Metab, 7, 157
- 10.1093/ajcn/79.3.362 · DOI · Paper page
- 10.1111/j.1464-5491.2008.02636.x · DOI · Paper page
- 10.1016/S0306-9877(03)00227-5 · DOI · Paper page
- Major, 2007, Supplementation with calcium+vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations, Am J Clin Nutr, 85, 54
- 10.1056/NEJM199709043371003 · DOI · Paper page
- 10.1074/jbc.274.48.34343 · DOI · Paper page
- 10.1079/BJN2003837 · DOI · Paper page
- 10.1001/jama.289.19.2560 · DOI · Paper page
- 10.1001/archinte.167.11.1159 · DOI · Paper page
- 10.1359/jbmr.1998.13.3.325 · DOI · Paper page
- 2007, Deaths from Principal Causes Registered in the Years 1998 to 2005
- 10.1016/0021-9150(72)90013-5 · doi:10.1016/0021-9150(72)90013-5
- 10.1210/jc.2003-030358 · DOI · Paper page
- 10.2165/00002512-200421010-00002 · DOI
- 10.1111/j.1753-4887.2008.00096.x · DOI · Paper page
- 10.1677/joe.0.1600087 · DOI · Paper page
- 10.1159/000097812 · DOI
- 2001, Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary
- 10.1096/fasebj.14.9.1132 · DOI · Paper page
- 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications
- 10.1016/S0026-0495(97)90212-2 · DOI
- 10.1248/bpb.28.1418 · DOI · Paper page
- 10.1097/MCO.0b013e328312c33f · DOI
- 10.1038/ki.2008.452 · DOI
- 10.1016/j.nut.2008.04.009 · DOI
- 10.1186/1475-2891-7-4 · DOI · Paper page
- 10.1093/ajcn/52.4.717 · DOI
- 10.1056/NEJM198512193132501 · DOI · Paper page
- 10.1016/j.thromres.2009.12.011 · DOI
- 10.1186/1471-2350-2-2 · DOI
- 10.1159/000069761 · DOI · Paper page
- 10.2337/db07-1122 · DOI · Paper page
- 10.1001/archinternmed.2007.31 · DOI · Paper page
- 10.1093/ndt/gfp354 · DOI
- 10.1152/ajpendo.00224.2004 · DOI · Paper page
- Lee, 1990, The Irish National Nutrition Survey
- 10.2337/diabetes.51.7.2294 · DOI · Paper page
- 10.1161/01.HYP.0000182662.82666.37 · DOI
- 10.2337/diabetes.47.4.688 · DOI
- 10.1139/y75-157 · doi:10.1139/y75-157
- 10.1053/meta.2001.20172 · DOI
- 10.1210/jc.2003-031398 · DOI · Paper page
- 10.1001/jama.286.3.327 · DOI · Paper page
- 10.1093/qjmed/89.8.579 · DOI · Paper page
- 10.2337/diacare.28.12.2926 · DOI · Paper page
- 10.1017/S0007114508030808 · DOI · Paper page
- 10.1016/j.cyto.2009.12.006 · DOI
- 10.1136/bmj.326.7387.469 · DOI · Paper page
- 10.3109/03008209609029208 · DOI
- 10.1161/CIRCULATIONAHA.105.171600 · DOI · Paper page
- 10.1016/S0140-6736(05)60827-6 · DOI · Paper page
- 10.1136/bmj.2.6183.176 · DOI
- 10.1093/gerona/glp006 · DOI · Paper page
- 10.1007/BF03347358 · DOI
- 10.1097/HCO.0b013e32832ac21a · DOI · Paper page
- 10.1016/j.metabol.2008.06.008 · DOI
- 10.1016/S0022-5347(01)66305-5 · doi:10.1016/s0022-5347(01)66305-5
- 10.1016/S0140-6736(87)93050-9 · DOI · Paper page
- 10.1016/S0140-6736(05)67402-8 · DOI · Paper page
- 10.1186/1475-2840-8-7 · DOI · Paper page
- 10.1079/PHN2001191 · DOI
- 10.2337/dc06-0946 · DOI · Paper page
- Ballermann, 1991, Endothelium-derived vasoactive mediators and renal glomerular function, Clin Invest Med, 14, 508
- 10.2337/db08-0593 · DOI · Paper page
- 10.1016/j.maturitas.2009.12.013 · DOI · Paper page
- 10.1530/EJE-08-0339 · DOI · Paper page
- 10.3945/ajcn.2008.27004 · DOI · Paper page
- 10.1111/j.1463-1326.2007.00710.x · DOI · Paper page
- 10.1096/fj.01-0584fje · DOI · Paper page
- 10.1146/annurev.immunol.19.1.683 · DOI · Paper page
- Scragg, 1995, Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults, Eur J Clin Nutr, 49, 640
- 10.3945/jn.108.093831 · DOI · Paper page
- Abdelkefi, 2007, Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection, J Support Oncol, 5, 273
- 10.1161/hc0902.104353 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.106.673491 · DOI · Paper page
- 10.1007/s00394-008-0700-4 · DOI · Paper page
- 10.1001/archinte.167.9.893 · DOI · Paper page
- Morgan, 2008, SLÁN 2007, Survey of Lifestyle, Attitudes and Nutrition in Ireland. Main Report
- 10.1038/nrcardio.2009.135 · DOI · Paper page
- 10.1080/07315724.2001.10719180 · DOI · Paper page
- 10.1038/ejcn.2008.79 · DOI
- 10.1038/ki.2008.101 · DOI · Paper page
- 10.1093/ajcn/87.1.136 · DOI · Paper page
- 10.1210/jc.2007-0722 · DOI · Paper page
- 10.1074/jbc.M705495200 · DOI · Paper page
- 10.1161/01.HYP.30.2.150 · DOI · Paper page
- 10.2337/dc06-2438 · DOI · Paper page
- 10.1093/ajcn/71.6.1530 · doi:10.1093/ajcn/71.6.1530
- 10.1161/HYPERTENSIONAHA.108.117630 · DOI · Paper page
- 10.1096/fj.01-0433rev · DOI · Paper page
- 10.2337/diacare.29.03.06.dc05-1961 · DOI · Paper page
- 10.1161/HYPERTENSIONAHA.108.114991 · DOI · Paper page
- 10.1046/j.1365-2249.2000.01204.x · DOI · Paper page
- 10.1001/jama.1996.03540070040028 · DOI · Paper page
- 10.1016/j.atherosclerosis.2008.10.033 · DOI · Paper page
- 10.1079/BJN2001508 · DOI
- Denke, 1993, Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men, J Nutr, 123, 1047, 10.1093/jn/123.6.1047 · DOI · Paper page
- 10.1093/ajcn/82.3.517 · doi:10.1093/ajcn/82.3.517
- 10.3945/ajcn.2009.28579 · DOI
- 10.2337/diabetes.48.8.1607 · DOI · Paper page
- 10.1016/j.jdiacomp.2008.12.002 · doi:10.1016/j.jdiacomp.2008.12.002
- 10.1016/0378-5122(95)00909-5 · DOI
- 10.1016/j.jsbmb.2005.06.002 · DOI · Paper page
- 10.1016/j.jsbmb.2009.01.003 · DOI
- 10.3181/00379727-149-38742 · doi:10.3181/00379727-149-38742
- 10.1016/j.bbalip.2005.09.004 · DOI
- 10.1161/01.CIR.102.1.42 · DOI · Paper page
- 10.1159/000054213 · doi:10.1159/000054213
- 10.1007/s00394-010-0098-7 · DOI · Paper page
- 10.1093/ajcn/42.1.135 · DOI
- 10.1016/S0165-5728(02)00396-X · DOI · Paper page
- 10.1016/S1471-4914(02)02294-3 · DOI · Paper page
- 10.1002/jbmr.5650081003 · DOI
- 10.1016/j.cellbi.2006.01.004 · DOI
- 10.3164/jcbn.13.45 · DOI
- 10.1038/ncpendmet0716 · DOI · Paper page
- 10.1016/j.amjhyper.2007.01.017 · DOI · Paper page
- 10.1210/jc.2007-0298 · DOI · Paper page
- 10.1079/BJN20051544 · DOI · Paper page
- 10.1038/ejcn.2009.18 · DOI
- 10.1093/qjmed/95.12.787 · DOI · Paper page
- 10.1053/meta.2002.29969 · DOI · Paper page
- 10.1093/ajcn/79.5.820 · DOI · Paper page
- 10.1172/JCI111971 · DOI · Paper page
- 10.2337/diacare.26.11.3198-a · DOI
- 10.1080/13685530802273426 · DOI
- 10.1001/archinte.168.11.1174 · DOI · Paper page
- 10.1053/meta.2000.17708 · DOI · Paper page
- 10.1111/j.1468-3083.2009.03245.x · DOI
- 10.1210/jc.2009-1797 · DOI
- 10.1007/s00125-006-0190-y · DOI
- 10.1016/S0021-9150(98)00174-9 · DOI
- 10.1186/1476-9255-5-10 · DOI · Paper page
- Hass, 1966, Production of calcific athero-arteriosclerosis and thromboarteritis with nicotine, vitamin D and dietary cholesterol, Am J Pathol, 49, 739
- Barger-Lux, 1995, An investigation of sources of variation in calcium absorption efficiency, J Clin Endocrinol Metab, 80, 406
- 10.1096/fj.02-0424fje · DOI · Paper page
- 10.1016/j.atherosclerosis.2005.06.046 · DOI · Paper page
- 10.2337/diacare.28.5.1228 · DOI · Paper page
- 10.1210/jc.2007-2308 · DOI · Paper page
- Cox, 1990, Clinical Methods: The History, Physical and Laboratory Examinations, 153
- 10.1002/eji.200425491 · DOI · Paper page
- 10.1016/j.bone.2009.02.020 · DOI
Cited by
Ganji, V., Zhang, X., Shaikh, N., & Tangpricha, V. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.013516 · Cited by 189
“In contrast, vitamin D intervention studies have yielded inconsistent results on lowering IR (46).”
ResultGower, B. A., Alvarez, J. A., Bush, N. C., & Hunter, G. R. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-3 · Cited by 25
Fortunato, F., Demartini, B., Maffoni, C., Apicella, E., Leonardi, V., & Mendolicchio, L. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.043 · Cited by 11
Metadata
- Authors
- Muldowney, S., & Kiely, M.
- Venue
- Nutrition Research Reviews
- Publisher
- Cambridge University Press (CUP)
- Published
- 2010-12-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-20
- ISSN
- 0954-4224 (ISSN-L)
- 1475-2700
- OpenAlex
- W2129136569
- Cited by
- 68
- References
- 23
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D and cardiometabolic health: a review of the evidence. https://app.cochat.ai/papers/10.1017/s0954422410000259
- The paper
- Muldowney, S., & Kiely, M. (2011). Vitamin D and cardiometabolic health: a review of the evidence. Nutrition Research Reviews. https://doi.org/10.1017/s0954422410000259
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.